留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

应中央军委要求,2022年9月起,《药学实践杂志》将更名为《药学实践与服务》,双月刊,正文96页;2023年1月起,拟出版月刊,正文64页,数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿!

网络药理学在中药作用机制中的研究进展

邢心睿 吕狄亚 柴逸峰 朱臻宇

邢心睿, 吕狄亚, 柴逸峰, 朱臻宇. 网络药理学在中药作用机制中的研究进展[J]. 药学实践与服务, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
引用本文: 邢心睿, 吕狄亚, 柴逸峰, 朱臻宇. 网络药理学在中药作用机制中的研究进展[J]. 药学实践与服务, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
XING Xinrui, LÜ Diya, CHAI Yifeng, ZHU Zhenyu. Advances in the mechanism of Traditional Chinese Medicine by network pharmacology method[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
Citation: XING Xinrui, LÜ Diya, CHAI Yifeng, ZHU Zhenyu. Advances in the mechanism of Traditional Chinese Medicine by network pharmacology method[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001

网络药理学在中药作用机制中的研究进展

doi: 10.3969/j.issn.1006-0111.2018.02.001
基金项目: 国家自然科学基金(81773683)

Advances in the mechanism of Traditional Chinese Medicine by network pharmacology method

  • 摘要: 网络药理学以系统生物学为基础,系统阐述了机体与药物相互作用的原理与规律,代表了现代生物医药的哲学理念与研究模式。运用网络药理学相关的技术手段,更便于理解中药治疗疾病的作用机制,目前网络药理学已被广泛应用于中药研究。从网络药理学及网络药理学应用等方面,介绍近年网络药理学在中药领域的运用与发展。
  • [1] Hopkins AL. Network pharmacology:the next paradigm in drug discovery[J]. Nat Chem Biol,2008,4(11), 682-690.
    [2] Fang J, Wang L, Wu T,et al. Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment[J]. J Ethnopharmacol,2017,196:281-292.
    [3] 李梢.网络靶标:中药方剂网络药理学研究的一个切入点[J].中国中药杂志,2011,36(15):2017-2020.
    [4] Yang M, Chen JL, Xu LW, et al. Navigating traditional chinese medicine network pharmacology and computational tools[J]. Evidence-based Complement Altern Med,2013, 2013:731969.
    [5] 薛潇春,胡晋红.网络药理学的研究方法与应用进展[J].药学实践杂志,2015,33(5):401-405.
    [6] 周文霞,王同兴,程肖蕊,等. 网络药理学研究中的网络构建技术[J].国际药学研究杂志,2016,43(5):791-812.
    [7] 何艳,于云莉,杨帆.基于复杂网络可视化的癫痫患者大脑状态研究[J]. 中国医疗设备,2016,31(9):39-42.
    [8] Lecca P, Re A. Network-oriented approaches to anticancer drug response[J]. Cancer Gene Networks,2016,03:101-117.
    [9] 周文霞,王同兴,程肖蕊,等.网络药理学研究中的网络分析技术[J].国际药学研究杂志,2016,43(3):399-409.
    [10] Li B,Xu X,Wang X, et al. A systems biology approach to understanding the mechanisms of action of Chinese herbs for treatment of cardiovascular disease[J]. Int J Molecul Sci,2012,13(10):13501-13520.
    [11] Tao W, Xu X, Wang X, et al. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease[J].J Ethnopharmacol,2013, 145(1):1-10.
    [12] Li X, Wu L, Liu W, et al.A networkpharmacology study of Chinese medicine QiShenYiQi to reveal its underlying multi-compound, multi-target, multi-pathway mode of action[J]. PloS ONE,2014, 9(5):e95004.
    [13] Fang HY, Zeng HW, Lin LM, et al. A network-based method for mechanistic investigation of Shexiang Baoxin Pill's treatment of cardiovascular diseases[J]. Sci Rep, 2017,7:43632.
    [14] Hong M, Wang N,Feng Y,et al. A Biomedical investigation of the hepatoprotective effect of Radix salviae miltiorrhizae and network pharmacology-based prediction of the active compounds and molecular targets[J]. Int J Molecul Sci,2017,18(3):620.
    [15] An L, Feng F.Network pharmacology-based antioxidant effect study of zhi-zi-da-huang decoction for alcoholic liver disease[J]. Evidence-based Complement Altern Med,2015,2015:492470.
    [16] Zhang B, Lu C, Bai M,et al.Tetramethylpyrazine identified by a network pharmacology approach ameliorates methotrexate-induced oxidative organ injury[J]. J Ethnopharmacol,2015,175:638-647.
    [17] Wei S, Niu M, Wang J, et al.A network pharmacology approach to discover active compounds and action mechanisms of San-Cao Granule for treatment of liver fibrosis[J]. Drug Design Development and Therapy,2016, 10:733-743.
    [18] van Berlo D,Hullmann M,Schins RP.Toxicology of ambient particulate matter[J]. Molecul, Clini Environment Toxicol,2012,101:165-217.
    [19] Yu G, Zhang Y, Ren W, et al.Network pharmacology-based identification of key pharmacological pathways of Yin-Huang-Qing-Fei capsule acting on chronic bronchitis[J]. In J Chron Obstruct Pulmon Dis,2017, 12:85-94.
    [20] Hou Y, Nie Y, Cheng B,et al.Qingfei Xiaoyan Wan, a traditional Chinese medicine formula, ameliorates Pseudomonas aeruginosa-induced acute lung inflammation by regulation of PI3K/AKT and Ras/MAPK pathways[J]. Acta Pharmaceutica Sinica B,2016,6(3):212-221.
    [21] Tao J, Hou Y, Ma X,et al. An integrated global chemomics and system biology approach to analyze the mechanisms of the traditional Chinese medicinal preparation Eriobotrya japonica-Fritillaria usuriensis dropping pills for pulmonary diseases[J]. BMC Complement Altern Med,2016,16:4.
    [22] Xiang Z, Sun H, Cai X,et al. The study on the material basis and the mechanism for anti-renal interstitial fibrosis efficacy of rhubarb through integration of metabonomics and network pharmacology[J]. Molecular Biosystems, 2015,11(4):1067-1078.
    [23] Shi SH, Cai YP, Cai XJ, et al. A network pharmacology approach to understanding the mechanisms of action of traditional medicine:Bushenhuoxue formula for treatment of chronic kidney disease[J]. PloS ONE,2014,9(3):e89123.
    [24] Wang J,Yao K,Yang X,et al.Chinese patent medicineliu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension:a systematic review of randomized controlled trials[J]. Evidence-based Complement Altern Med, 2012, 2012:714805.
    [25] Liang X, Li H, Li S. A novel network pharmacology approach to analyse traditional herbal formulae:the Liu-Wei-Di-Huang pill as a case study[J]. Molecular Biosystems,2014,10(5):1014-1022.
    [26] Wang HH,Zhang BX,Ye XT, et al. Study on mechanism for anti-depression efficacy of Sini San through auxiliary mechanism elucidation system for Chinese medicine[J]. Zhongguo Zhong Yao Za Zhi,2015,40(19):3723-3728.
    [27] Margineanu DG. Systems biology, complexity, and the impact on antiepileptic drug discovery[J]. Epilepsy Behav,2014,38:131-142.
    [28] Guo Q, Mao X, Zhang Y,et al. Guizhi-Shaoyao-Zhimu decoction attenuates rheumatoid arthritis partially by reversing inflammation-immune system imbalance[J]. J Transl Med, 2016,14(1):165.
    [29] Zhang Y, Wang D, Tan S, et al. A systems biology-based investigation into the pharmacological mechanisms of wu tou tang acting on rheumatoid arthritis by integrating network analysis[J]. Evidence-based Complement Altern Med,2013,2013:548498.
    [30] Zhang Y, Mao X, Guo Q, et al. Pathway of PPAR-gamma coactivators in thermogenesis:a pivotal traditional Chinese medicine-associated target for individualized treatment of rheumatoid arthritis[J]. Oncotarget,2016,7(13):15885-15900.
    [31] Chen Y, Palczewski K. Systems pharmacology links GPCRs with retinal degenerative disorders[J]. Ann Rev Pharmacol Toxicol,2016,56:273-298.
    [32] Liu H, Zeng L, Yang K. A network pharmacology approach to explore the pharmacological mechanism of Xiaoyao powder on anovulatory infertility[J]. Evidence-based Complement Altern Med,2016,2016:1-13.
    [33] Tang F, Tang Q, Tian Y,et al. Network pharmacology-based prediction of the active ingredients and potential targets of Mahuang Fuzi Xixin decoction for application to allergic rhinitis[J]. J Ethnopharmacol,2015,176:402-412.
  • [1] 张修平, 田家盛, 王道鑫, 李佳鑫, 王品, 缪朝玉.  MT-1207对小鼠血糖、血脂和动脉粥样硬化的作用 . 药学实践与服务, 2024, 42(11): 487-494. doi: 10.12206/j.issn.2097-2024.202306011
    [2] 杨彬, 王作君, 陈菡, 张敬一.  基于DRGs的医院合理用药管理机制探索实践 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404030
    [3] 郭灵怡, 刘艳超, 高路, 刘瑞瑶, 吕权真, 俞媛.  醋酸卡泊芬净单硬脂酸甘油酯纳米粒抗白色念珠菌感染的增效作用研究 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202310043
    [4] 丁华敏, 郭羽晨, 秦春霞, 宋志兵, 孙莉莉.  消风止痒颗粒通过降低白三烯水平对小鼠特应性皮炎急性瘙痒的治疗作用研究 . 药学实践与服务, 2024, 42(5): 211-216. doi: 10.12206/j.issn.2097-2024.202306031
    [5] 夏哲炜, 曾垣烨, 朱海菲, 李育, 陈啸飞.  核磁共振磷谱法测定磷酸氢钙咀嚼片中药物含量 . 药学实践与服务, 2024, 42(9): 399-401, 406. doi: 10.12206/j.issn.2097-2024.202404063
    [6] 钱淑雨, 李铁军.  耐碳青霉烯类肠杆菌耐药机制的研究进展 . 药学实践与服务, 2024, 42(10): 419-425. doi: 10.12206/j.issn.2097-2024.202405005
    [7] 徐飞, 陈瑾, 鲁育含, 李志勇.  肠道菌群参与糖尿病肾病的机制研究进展 . 药学实践与服务, 2024, 42(5): 181-184, 197. doi: 10.12206/j.issn.2097-2024.202312023
    [8] 岳春华, 贲永光, 王海桥.  基于NLRP1炎症小体探讨百合知母汤抗抑郁的作用机制 . 药学实践与服务, 2024, 42(8): 325-333. doi: 10.12206/j.issn.2097-2024.202401033
    [9] 修建平, 杨朝爱, 刘禧澳, 潘乾禹, 韦广旭, 王卫星.  全反式维甲酸对肝星状细胞活化及氧化应激的作用和机制探索 . 药学实践与服务, 2024, 42(7): 291-296. doi: 10.12206/j.issn.2097-2024.202312054
    [10] 陈莹, 许子华, 胡北, 崔亚玲, 高欢, 吴琼.  通便灵胶囊治疗便秘的药效与机制研究 . 药学实践与服务, 2024, 42(): 1-7. doi: 10.12206/j.issn.2097-2024.202404008
    [11] 张广雨, 杜晶, 刘梦珍, 朱丹妮, 闫慧, 刘冲.  新斯的明与山莨菪碱联合应用对肺型氧中毒的保护作用及其机制的研究 . 药学实践与服务, 2024, 42(10): 433-438, 444. doi: 10.12206/j.issn.2097-2024.202310049
    [12] 赖立勇, 夏天爽, 徐圣焱, 蒋益萍, 岳小强, 辛海量.  中药青蒿抗氧化活性的谱效关系研究 . 药学实践与服务, 2024, 42(5): 203-210, 216. doi: 10.12206/j.issn.2097-2024.202211012
    [13] 景凯, 杨慈荣, 张圳, 臧艺蓓, 刘霞.  黄芪甲苷衍生物治疗慢性心力衰竭小鼠的药效评价及作用机制研究 . 药学实践与服务, 2024, 42(5): 190-197. doi: 10.12206/j.issn.2097-2024.202310004
    [14] 李清, 郭宜银, 陈颖, 瞿发林, 董文燊, 戈煜.  夜宁胶囊对小鼠镇静催眠作用及其机制的研究 . 药学实践与服务, 2024, 42(8): 346-349. doi: 10.12206/j.issn.2097-2024.202211047
    [15] 张成中, 朱雪艳, 卜其涛, 王宏瑞, 黄宝康.  基于网络药理学与分子对接预测鸡骨草特征图谱研究 . 药学实践与服务, 2024, 42(8): 350-358. doi: 10.12206/j.issn.2097-2024.202303048
    [16] 张林晨, 张小琴, 张俊平.  山楂酸药理作用的研究进展 . 药学实践与服务, 2024, 42(5): 185-189. doi: 10.12206/j.issn.2097-2024.202307052
    [17] 陈金涛, 乔子婴, 马明华, 张若曦, 王振伟, 年华.  基于网络药理学和分子对接技术研究金芪清疏颗粒治疗社区获得性肺炎的潜在机制 . 药学实践与服务, 2024, 42(11): 471-478. doi: 10.12206/j.issn.2097-2024.202312014
    [18] 徐璐璐, 刘爱军.  丹参白术方“异病同治”冠心病、血管性痴呆、特发性膜性肾病的网络药理学作用机制研究 . 药学实践与服务, 2024, 42(12): 1-8. doi: 10.12206/j.issn.2097-2024.202312027
    [19] 姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量.  巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 285-290, 296. doi: 10.12206/j.issn.2097-2024.202305011
    [20] 陈静, 何瑞华, 翁月, 徐熠, 刘静, 黄瑾.  基于网络药理学和分子对接技术探究定清片活性成分治疗白血病的作用机制 . 药学实践与服务, 2024, 42(11): 479-486. doi: 10.12206/j.issn.2097-2024.202401073
  • 加载中
计量
  • 文章访问数:  8443
  • HTML全文浏览量:  1142
  • PDF下载量:  1183
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-09-11
  • 修回日期:  2017-11-03

网络药理学在中药作用机制中的研究进展

doi: 10.3969/j.issn.1006-0111.2018.02.001
    基金项目:  国家自然科学基金(81773683)

摘要: 网络药理学以系统生物学为基础,系统阐述了机体与药物相互作用的原理与规律,代表了现代生物医药的哲学理念与研究模式。运用网络药理学相关的技术手段,更便于理解中药治疗疾病的作用机制,目前网络药理学已被广泛应用于中药研究。从网络药理学及网络药理学应用等方面,介绍近年网络药理学在中药领域的运用与发展。

English Abstract

邢心睿, 吕狄亚, 柴逸峰, 朱臻宇. 网络药理学在中药作用机制中的研究进展[J]. 药学实践与服务, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
引用本文: 邢心睿, 吕狄亚, 柴逸峰, 朱臻宇. 网络药理学在中药作用机制中的研究进展[J]. 药学实践与服务, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
XING Xinrui, LÜ Diya, CHAI Yifeng, ZHU Zhenyu. Advances in the mechanism of Traditional Chinese Medicine by network pharmacology method[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
Citation: XING Xinrui, LÜ Diya, CHAI Yifeng, ZHU Zhenyu. Advances in the mechanism of Traditional Chinese Medicine by network pharmacology method[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(2): 97-102. doi: 10.3969/j.issn.1006-0111.2018.02.001
参考文献 (33)

目录

    /

    返回文章
    返回